By Peter Nurse
Investing.com -- Stocks in focus in premarket trade on Thursday, September 22nd. Please refresh for updates.
-
Lennar (NYSE:LEN) stock fell 1.5% after the homebuilder reported better-than-expected third-quarter results, boosted by record high prices, but new home sales disappointed.
- Darden Restaurants (NYSE:DRI) stock fell 3.3% after the Olive Garden owner said same-restaurant sales rose by 4.2% on the quarter, below expectations.
-
H.B. Fuller (NYSE:FUL) stock rose 2.2% after the adhesives company beat quarterly earnings expectations, citing “robust pricing actions to recover unprecedented raw material cost inflation.”
-
Accenture (NYSE:ACN) stock fell 0.3% after the IT services firm forecast first-quarter revenue below expectations, weighed down by IT spending cuts amid high inflation and impact from a stronger dollar.
-
Eli Lilly (NYSE:LLY) stock rose 1.8% after UBS upgraded its investment stance on the pharma company to ‘buy’ from ‘neutral’, citing the likely benefits of futures sales of a key weight loss drug.
-
Salesforce (NYSE:CRM) stock rose 2.5% after the cloud-based software company announced plans for a 25% operating margin by 2026, seeking to operate much more efficiently.
-
Target (NYSE:TGT) stock rose 0.2% after the big-box retailer announced plans to hire up to 100,000 seasonal workers for the holiday season and start offering festive deals earlier than ever.
-
Manchester United (NYSE:MANU) stock will be in focus after the English soccer club reported a net loss of 70.7 million pounds for the three months to June 30, a narrowing from a loss of 107.7 million pounds a year earlier.
-
Nike (NYSE:NKE) stock rose 0.7% after RBC (TSX:RY) initiated coverage of the retailer at ‘outperform’, saying the “100lb gorilla in sportswear” is set to surge almost 30%.
-
Novavax (NASDAQ:NVAX) stock fell 5.7% after JPMorgan downgraded its stance on the drug maker to 'underweight' from 'neutral'. citing reduced vaccine demand.